ECE-1 Antibodies

Santa Cruz Biotechnology offers a broad range of ECE-1 monoclonal antibodies for research focused on understanding endothelin-converting enzyme 1. ECE-1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Endothelin-converting enzyme 1 is crucial for the conversion of big endothelin-1 to its active form, playing a significant role in regulating vascular tone and blood pressure. Dysregulation of ECE-1 has been implicated in various cardiovascular diseases, making it an important target for therapeutic intervention. Understanding ECE-1 function can provide insights into the mechanisms underlying cardiovascular conditions and aid in the development of new treatment strategies. ECE-1 research continues to reveal new pathways and mechanisms in cardiovascular biology. Investigating ECE-1 expression patterns helps researchers better understand vascular system regulation. Current studies focusing on ECE-1 are uncovering potential therapeutic approaches for cardiovascular disorders. Santa Cruz Biotechnology monoclonal antibodies for ECE-1 enable researchers worldwide to advance scientific understanding of cardiovascular health and disease.